[go: up one dir, main page]

PT1200399E - Analogos de vitamina d3 - Google Patents

Analogos de vitamina d3

Info

Publication number
PT1200399E
PT1200399E PT00954438T PT00954438T PT1200399E PT 1200399 E PT1200399 E PT 1200399E PT 00954438 T PT00954438 T PT 00954438T PT 00954438 T PT00954438 T PT 00954438T PT 1200399 E PT1200399 E PT 1200399E
Authority
PT
Portugal
Prior art keywords
analogs
vitamin
Prior art date
Application number
PT00954438T
Other languages
English (en)
Inventor
Bernard Michael Hennessy
Milan Radoje Uskokovic
Andrew David Batcho
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PT1200399E publication Critical patent/PT1200399E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT00954438T 1999-07-12 2000-07-06 Analogos de vitamina d3 PT1200399E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14341399P 1999-07-12 1999-07-12

Publications (1)

Publication Number Publication Date
PT1200399E true PT1200399E (pt) 2004-06-30

Family

ID=22503954

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00954438T PT1200399E (pt) 1999-07-12 2000-07-06 Analogos de vitamina d3

Country Status (36)

Country Link
US (1) US6331642B1 (pt)
EP (1) EP1200399B1 (pt)
JP (1) JP3803579B2 (pt)
KR (1) KR100477161B1 (pt)
CN (1) CN1174964C (pt)
AR (1) AR024695A1 (pt)
AT (1) ATE262508T1 (pt)
AU (1) AU779408B2 (pt)
BR (1) BR0012419A (pt)
CA (1) CA2378803C (pt)
CO (1) CO5190683A1 (pt)
DE (1) DE60009303T2 (pt)
DK (1) DK1200399T3 (pt)
EG (1) EG23909A (pt)
ES (1) ES2215707T3 (pt)
GC (1) GC0000198A (pt)
HK (1) HK1047578B (pt)
HR (1) HRP20020007A2 (pt)
HU (1) HUP0202157A3 (pt)
IL (2) IL147254A0 (pt)
JO (1) JO2255B1 (pt)
MA (1) MA26808A1 (pt)
MX (1) MXPA02000313A (pt)
MY (1) MY122633A (pt)
NO (1) NO20020161D0 (pt)
NZ (1) NZ516339A (pt)
PE (1) PE20010328A1 (pt)
PL (1) PL201877B1 (pt)
PT (1) PT1200399E (pt)
RS (1) RS50229B (pt)
RU (1) RU2235721C2 (pt)
TR (1) TR200200054T2 (pt)
TW (1) TWI268276B (pt)
UY (1) UY26239A1 (pt)
WO (1) WO2001004089A1 (pt)
ZA (1) ZA200110487B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002013832A1 (fr) * 2000-08-17 2002-02-21 Chugai Seiyaku Kabushiki Kaisha Agent therapeutique destine au traitement de l'osteoporose
AU2001296542B2 (en) 2000-10-02 2007-10-25 Emory University Triptolide analogs for the treatment of autoimmune and inflammatory disorders
CA2459789A1 (en) * 2001-09-21 2003-04-03 F. Hoffmann-La Roche Ag 3-desoxy-vitamin d3 analog esters
US8034831B2 (en) 2002-11-06 2011-10-11 Celgene Corporation Methods for the treatment and management of myeloproliferative diseases using 4-(amino)-2-(2,6-Dioxo(3-piperidyl)-isoindoline-1,3-dione in combination with other therapies
US7563810B2 (en) 2002-11-06 2009-07-21 Celgene Corporation Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases
JP2006525367A (ja) * 2003-04-30 2006-11-09 ビオクセル エッセ ピ ア ジェミニビタミンｄ３化合物及びその使用方法
US20050113348A1 (en) * 2003-06-12 2005-05-26 Yanchun Li Vitamin D and vitamin D analogs or derivatives as new anti-hypertensive agents
PT103177A (pt) * 2003-09-24 2005-03-31 Bioxell Spa 1-alfa-fluoro-25-hidroxi-16,23e-dieno-26,27-bis-homo-20-epi-colecalciferol, seus sais ou esteres e sua utilizacao no fabrico de medicamentos
WO2005030223A1 (en) * 2003-09-24 2005-04-07 Bioxell, S.P.A. Methods for treating bladder dysfunction
GB2407499B (en) * 2003-11-03 2008-02-27 Bioxell Spa Vitamin D3 analogue for use in the treatment of BPH
US8404667B2 (en) * 2006-12-29 2013-03-26 Wisconsin Alumni Research Foundation Compounds, compositions, kits and methods of use to orally and topically treat acne and other skin conditions by 19-Nor vitamin D analog
WO2006036813A2 (en) * 2004-09-24 2006-04-06 Bioxell S.P.A. 20-cycloalkyl,26,27-alkyl/haloalkyl vitamin d3 compounds and methods of use thereof
US20080293647A1 (en) 2004-11-12 2008-11-27 Luciano Adorini Combined Use Of Vitamin D Derivatives And Anti-Proliferative Agents For Treating Bladder Cancer
US20100009949A1 (en) * 2006-03-24 2010-01-14 Bioxell S.P.A. Novel method
EP2167516B1 (en) * 2007-05-30 2015-07-22 Opko IP Holdings II, Inc. Process for producing phosphine oxide vitamin d precursors
HRP20240722T1 (hr) 2008-04-11 2024-08-30 Chugai Seiyaku Kabushiki Kaisha Molekula koja se veže na antigene, koja se može ponavljano vezati na dvje ili više molekula antigena
EP2682386B1 (en) * 2011-03-02 2016-08-17 Nihon University Novel vitamin d receptor modulator with partial agonist activity
KR102523660B1 (ko) 2016-09-26 2023-04-19 (주)하이플 박스용 테두리 부재보강부재와 에셈블리컨테이너 원터치크립이 포함된 박스

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4749710A (en) 1985-05-01 1988-06-07 Hoffmann-La Roche Inc. Immunosuppressive agents
ZA8923B (en) * 1988-01-20 1989-09-27 Hoffmann La Roche 16-dehydro-vitamin d3-derivatives
US5087619A (en) * 1988-01-20 1992-02-11 Hoffman-La Roche Inc. Vitamin D3 analogs
CA2096105A1 (en) * 1992-10-07 1994-04-08 Enrico Giuseppe Baggiolini (Deceased) Vitamin d3 fluorinated analogs
US5401733A (en) * 1993-10-01 1995-03-28 Hoffmann-La Roche Inc. Stable and active metabolites of 1,25-dihydroxy-16-ene-cholecalciferol
US5428029A (en) * 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
US6040300A (en) * 1995-04-07 2000-03-21 Arch Development Corporation Method of preventing colon cancer with vitamin D3 analogues
AU708679B2 (en) 1996-03-21 1999-08-12 F. Hoffmann-La Roche Ag 1,25-dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives

Also Published As

Publication number Publication date
EG23909A (en) 2007-12-30
CN1174964C (zh) 2004-11-10
EP1200399B1 (en) 2004-03-24
ZA200110487B (en) 2003-03-20
AU779408B2 (en) 2005-01-20
HK1047578B (zh) 2005-04-29
JP3803579B2 (ja) 2006-08-02
DE60009303T2 (de) 2005-02-24
US6331642B1 (en) 2001-12-18
RU2235721C2 (ru) 2004-09-10
MA26808A1 (fr) 2004-12-20
PL201877B1 (pl) 2009-05-29
JP2003504354A (ja) 2003-02-04
WO2001004089A1 (en) 2001-01-18
ATE262508T1 (de) 2004-04-15
NO20020161L (no) 2002-01-11
BR0012419A (pt) 2002-03-26
RS50229B (sr) 2009-07-15
NZ516339A (en) 2003-07-25
YU92701A (sh) 2004-09-03
HK1047578A1 (en) 2003-02-28
IL147254A (en) 2006-07-05
CA2378803A1 (en) 2001-01-18
AR024695A1 (es) 2002-10-23
DK1200399T3 (da) 2004-07-19
CA2378803C (en) 2009-01-27
CN1360572A (zh) 2002-07-24
KR20020033728A (ko) 2002-05-07
HRP20020007A2 (en) 2003-04-30
HUP0202157A2 (en) 2002-10-28
EP1200399A1 (en) 2002-05-02
MXPA02000313A (es) 2002-06-21
ES2215707T3 (es) 2004-10-16
PE20010328A1 (es) 2001-03-22
KR100477161B1 (ko) 2005-03-18
TR200200054T2 (tr) 2002-06-21
CO5190683A1 (es) 2002-08-29
NO20020161D0 (no) 2002-01-11
DE60009303D1 (de) 2004-04-29
HUP0202157A3 (en) 2004-04-28
PL356124A1 (en) 2004-06-14
UY26239A1 (es) 2000-10-31
TWI268276B (en) 2006-12-11
AU6689400A (en) 2001-01-30
GC0000198A (en) 2006-03-29
IL147254A0 (en) 2002-08-14
JO2255B1 (en) 2004-10-07
MY122633A (en) 2006-04-29

Similar Documents

Publication Publication Date Title
PT1124779E (pt) Analogos da vitamina d
EE200100502A (et) Ühendid
PT1235777E (pt) Analogos da vitamina d
DE69935620D1 (de) Aufzug
TR199700415A3 (tr) D3 vitamini analoglari.
PT1200399E (pt) Analogos de vitamina d3
PT1218009E (pt) Grandulos de quetiapina
PT1218096E (pt) Microcapsulas de libertacao variavel
PT1235824E (pt) Analogos da vitamina d
DE60024751D1 (de) Getriebeentlüftung
DE69932640D1 (de) Fahrtreppe
NO20013769D0 (no) Kalsilytiske forbindelser
DE60235195D1 (de) Vitamin-d-analoga
PT1163256E (pt) Hemi-hidrato de 16-alfa-bromoepiandrosterona
PT1167260E (pt) Derivados de vitamina d3
PT1235566E (pt) Formulacao injectavel de valnemulina
PT1176982E (pt) Solucao oral de prucaloprida
DE50010538D1 (de) Mehrkanal-Tropfengenerator
DE60007483D1 (de) Aufzug
PT1190776E (pt) Pulverizador de liquidos
ID29984A (id) Senyawa-senyawa bis-stirilbifenil
DK1380585T3 (da) Pyrazolopyridinon som mellemprodukt
SI1200399T1 (en) Vitamin d3 analogs
DE50004896D1 (de) Seitenbeschlag
DK1185524T3 (da) 3-Heteroarylalkylsubstituerede GAB-analoge